HCP Videos
Healthcare Professionals
Clinical resources to support the recognition, diagnosis, and management of neuroendocrine cancers.
NeuroEndocrine Cancer Australia (NECA) is committed to working alongside health professionals to improve outcomes for patients through raising awareness, knowledge-sharing, evidence based practice collaboration and education.
Neuroendocrine Tumours: A Guide for Healthcare Professionals
To request a copy of our printed booklet “Neuroendocrine Tumours: A Guide for Healthcare Professionals” please order online or click the “Download” link below.
Optimal Care Pathway for Healthcare Professionals
The Optimal Care Pathway (OCP) for Neuroendocrine Cancer supports clinicians to deliver consistent, evidence-based care and improve patient outcomes across Australia.
Access the Quick Reference Guide, Full OCP, or watch the overview video to learn more about its application in clinical practice.
Booklets & Guides
Neuroendocrine tumours: A guide for healthcare professionals
Educational Videos
Optimal Care Pathway for Neuroendocrine Tumours (NETs)
Booklets & Guides
Quick Reference Guide for Healthcare Professionals
Booklets & Guides
The Guide to Best Cancer Care for Neuroendocrine Cancer
Can you spot a neuroendocrine cancer?
Often mistaken for more common conditions, neuroendocrine cancers are the 7th most diagnosed cancer in Australia.
Improve diagnostic confidence and patient outcomes through our free, RACGP, ACRRM and ACN CPD-accredited courses.
Helpful Resources
Access evidence-based materials to support your understanding and management of neuroendocrine cancer
Booklets & Guides
About NETs
Clinical Trials
AUS-NET – Neuroendocrine Tumours
To improve patient quality of life and develop a cost-effective system that can be implemented across other rare cancers in the future.
Booklets & Guides
Basic Testing sheet for GastroEnteroPancreatic (GEP) Neuroendocrine Tumors (NETs)
Getting Diagnosed
Breaking Down the Latest NET Data: What Research Grants Are Revealing About Early Detection
Clinical Trials
Compose GEP-NET Phase III Trial
A phase III clinical trial investigating a new treatment option for advanced neuroendocrine tumors of gastroenteric or pancreatic origin (GEP-NETs)
Treatment Options
Emerging Immunotherapies for NETs
Getting Diagnosed
Genomic Profiling in Neuroendocrine Cancer
Causes & Risk Factors
Hereditary Factors in Neuroendocrine Tumours: Genetics, Risks, and Testing
Educational Videos
Lets Talk About Nuclear Medicine 27 April 2022
Treatment Options
